Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment
2022 · Nature Genetics · 492 citations
https://doi.org/10.1038/s41588-022-01141-9
I
Iman Osman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
714
Papers
19.1K
Citations
71
h-index
200
i10-index
Iman Osman is an academic researcher from Riyadh Armed Forces Hospital. The author has contributed to research in topics: Cutaneous Melanoma Detection and Management & Melanoma and MAPK Pathways & Cancer Immunotherapy and Biomarkers. The author has an h-index of 71, co-authored 607 publications.
ORCID: 0000-0002-1472-1971Papers by this author
worksChronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-risk Resected Melanoma
2021 · JAMA Oncology · 235 citations
https://doi.org/10.1001/jamaoncol.2021.0051
HER‐2 profiling and targeting in prostate carcinoma
2002 · Cancer · 138 citations
https://doi.org/10.1002/cncr.10339
Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors
2018 · Journal of Translational Medicine · 120 citations
https://doi.org/10.1186/s12967-018-1452-4
The ongoing racial disparities in melanoma: An analysis of the Surveillance, Epidemiology, and End Results database (1975-2016)
2020 · Journal of the American Academy of Dermatology · 120 citations
https://doi.org/10.1016/j.jaad.2020.08.097
The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo
2007 · Journal of Translational Medicine · 77 citations
https://doi.org/10.1186/1479-5876-5-49
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat